Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 190 entries
Sorted by: Best Match Show Resources per page
Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.

Public health action

Charambira K, Ade S, Harries AD, Ncube RT, Zishiri C, Sandy C, Mutunzi H, Takarinda K, Owiti P, Mafaune P, Chonzi P.
PMID: 27358806
Public Health Action. 2016 Jun 21;6(2):122-8. doi: 10.5588/pha.16.0005.

SETTING: In Zimbabwe, there are concerns about the management of tuberculosis (TB) patients with rifampicin (RMP) resistance diagnosed using Xpert(®) MTB/RIF.OBJECTIVE: To assess linkages between diagnosis and treatment for these patients in Harare and Manicaland provinces in 2014.DESIGN: A...

Cite
Charambira K, Ade S, Harries AD, et al. Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe. Public Health Action. 2016;6(2):122-8doi: 10.5588/pha.16.0005.
Charambira, K., Ade, S., Harries, A. D., Ncube, R. T., Zishiri, C., Sandy, C., Mutunzi, H., Takarinda, K., Owiti, P., Mafaune, P., & Chonzi, P. (2016). Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe. Public health action, 6(2), 122-8. https://doi.org/10.5588/pha.16.0005
Charambira, K, et al. "Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe." Public health action vol. 6,2 (2016): 122-8. doi: https://doi.org/10.5588/pha.16.0005
Charambira K, Ade S, Harries AD, Ncube RT, Zishiri C, Sandy C, Mutunzi H, Takarinda K, Owiti P, Mafaune P, Chonzi P. Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe. Public Health Action. 2016 Jun 21;6(2):122-8. doi: 10.5588/pha.16.0005. PMID: 27358806; PMCID: PMC4913675.
Copy Download .nbib Format: NLM
Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013.

Tuberculosis research and treatment

Takarinda KC, Sandy C, Masuka N, Hazangwe P, Choto RC, Mutasa-Apollo T, Nkomo B, Sibanda E, Mugurungi O, Harries AD, Siziba N.
PMID: 28352474
Tuberc Res Treat. 2017;2017:6232071. doi: 10.1155/2017/6232071. Epub 2017 Mar 02.

No abstract available.

Cite
Takarinda KC, Sandy C, Masuka N, et al. Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. Tuberc Res Treat. 2017;2017:6232071doi: 10.1155/2017/6232071.
Takarinda, K. C., Sandy, C., Masuka, N., Hazangwe, P., Choto, R. C., Mutasa-Apollo, T., Nkomo, B., Sibanda, E., Mugurungi, O., Harries, A. D., & Siziba, N. (2017). Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. Tuberculosis research and treatment, 20176232071. https://doi.org/10.1155/2017/6232071
Takarinda, Kudakwashe C, et al. "Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013." Tuberculosis research and treatment vol. 2017 (2017): 6232071. doi: https://doi.org/10.1155/2017/6232071
Takarinda KC, Sandy C, Masuka N, Hazangwe P, Choto RC, Mutasa-Apollo T, Nkomo B, Sibanda E, Mugurungi O, Harries AD, Siziba N. Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. Tuberc Res Treat. 2017;2017:6232071. doi: 10.1155/2017/6232071. Epub 2017 Mar 02. PMID: 28352474; PMCID: PMC5352882.
Copy Download .nbib Format: NLM
Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam.

Public health action

Phuong NT, Nhung NV, Hoa NB, Thuy HT, Takarinda KC, Tayler-Smith K, Harries AD.
PMID: 27051608
Public Health Action. 2016 Mar 21;6(1):25-31. doi: 10.5588/pha.15.0068. Epub 2016 Feb 11.

SETTING: The programmatic management of drug-resistant tuberculosis (TB) in Viet Nam has been rapidly scaled up since 2009.OBJECTIVES: To document the annual numbers of patients enrolled for multidrug-resistant tuberculosis (MDR-TB) treatment during 2010-2014 and to determine characteristics and treatment...

Cite
Phuong NT, Nhung NV, Hoa NB, et al. Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam. Public Health Action. 2016;6(1):25-31doi: 10.5588/pha.15.0068.
Phuong, N. T., Nhung, N. V., Hoa, N. B., Thuy, H. T., Takarinda, K. C., Tayler-Smith, K., & Harries, A. D. (2016). Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam. Public health action, 6(1), 25-31. https://doi.org/10.5588/pha.15.0068
Phuong, N T M, et al. "Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam." Public health action vol. 6,1 (2016): 25-31. doi: https://doi.org/10.5588/pha.15.0068
Phuong NT, Nhung NV, Hoa NB, Thuy HT, Takarinda KC, Tayler-Smith K, Harries AD. Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam. Public Health Action. 2016 Mar 21;6(1):25-31. doi: 10.5588/pha.15.0068. Epub 2016 Feb 11. PMID: 27051608; PMCID: PMC4809724.
Copy Download .nbib Format: NLM
Visfatin expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis.

Dental research journal

Tabari ZA, Keshani F, Sharbatdaran M, Banishahabadi A, Nejatifard M, Ghorbani H.
PMID: 29576773
Dent Res J (Isfahan). 2018 Mar-Apr;15(2):104-110.

BACKGROUND: Visfatin, also known as nicotinamide phosphoribosyltransferase, has been suggested as a pro-inflammatory and immunomodulating marker for periodontitis. The aim of this study was an immunohistochemical analysis of visfatin in gingival tissues of patients with chronic periodontitis and aggressive...

Cite
Tabari ZA, Keshani F, Sharbatdaran M, et al. Visfatin expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis. Dent Res J (Isfahan). 2018;15(2):104-110
Tabari, Z. A., Keshani, F., Sharbatdaran, M., Banishahabadi, A., Nejatifard, M., & Ghorbani, H. (2018). Visfatin expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis. Dental research journal, 15(2), 104-110.
Tabari, Zahra Alizadeh, et al. "Visfatin expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis." Dental research journal vol. 15,2 (2018): 104-110.
Tabari ZA, Keshani F, Sharbatdaran M, Banishahabadi A, Nejatifard M, Ghorbani H. Visfatin expression in gingival tissues of chronic periodontitis and aggressive periodontitis patients: An immunohistochemical analysis. Dent Res J (Isfahan). 2018 Mar-Apr;15(2):104-110. PMID: 29576773; PMCID: PMC5858068.
Copy Download .nbib Format: NLM
Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe?.

Public health action

Dlodlo RA, Hwalima ZE, Sithole S, Takarinda KC, Tayler-Smith K, Harries AD.
PMID: 26767174
Public Health Action. 2015 Dec 21;5(4):217-21. doi: 10.5588/pha.15.0036. Epub 2015 Nov 12.

SETTING: Emakhandeni Clinic provides decentralised and integrated tuberculosis (TB) and human immunodeficiency virus (HIV) care in Bulawayo, Zimbabwe.OBJECTIVES: To compare HIV care for presumptive TB patients with and without TB registered in 2013.DESIGN: Retrospective cohort study using routine programme...

Cite
Dlodlo RA, Hwalima ZE, Sithole S, et al. Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe?. Public Health Action. 2015;5(4):217-21doi: 10.5588/pha.15.0036.
Dlodlo, R. A., Hwalima, Z. E., Sithole, S., Takarinda, K. C., Tayler-Smith, K., & Harries, A. D. (2015). Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe?. Public health action, 5(4), 217-21. https://doi.org/10.5588/pha.15.0036
Dlodlo, R A, et al. "Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe?." Public health action vol. 5,4 (2015): 217-21. doi: https://doi.org/10.5588/pha.15.0036
Dlodlo RA, Hwalima ZE, Sithole S, Takarinda KC, Tayler-Smith K, Harries AD. Are HIV-positive presumptive tuberculosis patients without tuberculosis getting the care they need in Zimbabwe?. Public Health Action. 2015 Dec 21;5(4):217-21. doi: 10.5588/pha.15.0036. Epub 2015 Nov 12. PMID: 26767174; PMCID: PMC4682612.
Copy Download .nbib Format: NLM
Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health.

Journal of periodontal & implant science

Tabari ZA, Azadmehr A, Tabrizi MA, Hamissi J, Ghaedi FB.
PMID: 24236245
J Periodontal Implant Sci. 2013 Oct;43(5):227-32. doi: 10.5051/jpis.2013.43.5.227. Epub 2013 Oct 29.

PURPOSE: The receptor activator of nuclear factor kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system plays a significant role in osteoclastogenesis, activation of osteoclasts, and regulation of bone resorption. This study aimed to evaluate the use of the salivary soluble...

Cite
Tabari ZA, Azadmehr A, Tabrizi MA, et al. Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health. J Periodontal Implant Sci. 2013;43(5):227-32doi: 10.5051/jpis.2013.43.5.227.
Tabari, Z. A., Azadmehr, A., Tabrizi, M. A., Hamissi, J., & Ghaedi, F. B. (2013). Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health. Journal of periodontal & implant science, 43(5), 227-32. https://doi.org/10.5051/jpis.2013.43.5.227
Tabari, Zahra Alizadeh, et al. "Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health." Journal of periodontal & implant science vol. 43,5 (2013): 227-32. doi: https://doi.org/10.5051/jpis.2013.43.5.227
Tabari ZA, Azadmehr A, Tabrizi MA, Hamissi J, Ghaedi FB. Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health. J Periodontal Implant Sci. 2013 Oct;43(5):227-32. doi: 10.5051/jpis.2013.43.5.227. Epub 2013 Oct 29. PMID: 24236245; PMCID: PMC3825990.
Copy Download .nbib Format: NLM
Modulational instability, wave breaking, and formation of large-scale dipoles in the atmosphere.

Physical review letters

Iafrati A, Babanin A, Onorato M.
PMID: 23683204
Phys Rev Lett. 2013 May 03;110(18):184504. doi: 10.1103/PhysRevLett.110.184504. Epub 2013 May 03.

We use direct numerical simulation of the Navier-Stokes equations for a two-phase flow (water and air) to study the dynamics of the modulational instability of free surface waves and its contribution to the interaction between the ocean and atmosphere....

Cite
Iafrati A, Babanin A, Onorato M. Modulational instability, wave breaking, and formation of large-scale dipoles in the atmosphere. Phys Rev Lett. 2013;110(18):184504doi: 10.1103/PhysRevLett.110.184504.
Iafrati, A., Babanin, A., & Onorato, M. (2013). Modulational instability, wave breaking, and formation of large-scale dipoles in the atmosphere. Physical review letters, 110(18), 184504. https://doi.org/10.1103/PhysRevLett.110.184504
Iafrati, A, et al. "Modulational instability, wave breaking, and formation of large-scale dipoles in the atmosphere." Physical review letters vol. 110,18 (2013): 184504. doi: https://doi.org/10.1103/PhysRevLett.110.184504
Iafrati A, Babanin A, Onorato M. Modulational instability, wave breaking, and formation of large-scale dipoles in the atmosphere. Phys Rev Lett. 2013 May 03;110(18):184504. doi: 10.1103/PhysRevLett.110.184504. Epub 2013 May 03. PMID: 23683204.
Copy Download .nbib Format: NLM
Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007.

BMC research notes

Blöndal M, Ainla T, Marandi T, Baburin A, Eha J.
PMID: 22280560
BMC Res Notes. 2012 Jan 26;5:71. doi: 10.1186/1756-0500-5-71.

BACKGROUND: High quality care for acute myocardial infarction (AMI) improves patient outcomes. Still, AMI patients are treated in hospitals with unequal access to percutaneous coronary intervention. The study compares changes in treatment and 30-day and 3-year mortality of AMI...

Cite
Blöndal M, Ainla T, Marandi T, et al. Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007. BMC Res Notes. 2012;5:71doi: 10.1186/1756-0500-5-71.
Blöndal, M., Ainla, T., Marandi, T., Baburin, A., & Eha, J. (2012). Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007. BMC research notes, 571. https://doi.org/10.1186/1756-0500-5-71
Blöndal, Mai, et al. "Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007." BMC research notes vol. 5 (2012): 71. doi: https://doi.org/10.1186/1756-0500-5-71
Blöndal M, Ainla T, Marandi T, Baburin A, Eha J. Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007. BMC Res Notes. 2012 Jan 26;5:71. doi: 10.1186/1756-0500-5-71. PMID: 22280560; PMCID: PMC3293065.
Copy Download .nbib Format: NLM
Advanced cervical carcinoma in Ibadan, Nigeria: an appraisal of radiation therapy.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Campbell OB, Arowojolu AO, Akinlade BI, Adenipekun A, Babarinsa IA.
PMID: 15512681
J Obstet Gynaecol. 2000 Nov;20(6):624-7. doi: 10.1080/01443610020001503.

This is a retrospective study of 500 patients with advanced cervical cancer (FIGO Stages IIB, III and IVA) who were seen and managed at the University College Hospital Ibadan between 1988 and 1992. External pelvic radiation therapy plus intractivary...

Cite
Campbell OB, Arowojolu AO, Akinlade BI, et al. Advanced cervical carcinoma in Ibadan, Nigeria: an appraisal of radiation therapy. J Obstet Gynaecol. 2000;20(6):624-7doi: 10.1080/01443610020001503.
Campbell, O. B., Arowojolu, A. O., Akinlade, B. I., Adenipekun, A., & Babarinsa, I. A. (2000). Advanced cervical carcinoma in Ibadan, Nigeria: an appraisal of radiation therapy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 20(6), 624-7. https://doi.org/10.1080/01443610020001503
Campbell, O B, et al. "Advanced cervical carcinoma in Ibadan, Nigeria: an appraisal of radiation therapy." Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology vol. 20,6 (2000): 624-7. doi: https://doi.org/10.1080/01443610020001503
Campbell OB, Arowojolu AO, Akinlade BI, Adenipekun A, Babarinsa IA. Advanced cervical carcinoma in Ibadan, Nigeria: an appraisal of radiation therapy. J Obstet Gynaecol. 2000 Nov;20(6):624-7. doi: 10.1080/01443610020001503. PMID: 15512681.
Copy Download .nbib Format: NLM
Molecular characterization of the human COQ5 C-methyltransferase in coenzyme Q10 biosynthesis.

Biochimica et biophysica acta

Nguyen TP, Casarin A, Desbats MA, Doimo M, Trevisson E, Santos-Ocaña C, Navas P, Clarke CF, Salviati L.
PMID: 25152161
Biochim Biophys Acta. 2014 Nov;1841(11):1628-38. doi: 10.1016/j.bbalip.2014.08.007. Epub 2014 Aug 23.

Coq5 catalyzes the only C-methylation involved in the biosynthesis of coenzyme Q (Q or ubiquinone) in humans and yeast Saccharomyces cerevisiae. As one of eleven polypeptides required for Q production in yeast, Coq5 has also been shown to assemble...

Cite
Nguyen TP, Casarin A, Desbats MA, et al. Molecular characterization of the human COQ5 C-methyltransferase in coenzyme Q10 biosynthesis. Biochim Biophys Acta. 2014;1841(11):1628-38doi: 10.1016/j.bbalip.2014.08.007.
Nguyen, T. P., Casarin, A., Desbats, M. A., Doimo, M., Trevisson, E., Santos-Ocaña, C., Navas, P., Clarke, C. F., & Salviati, L. (2014). Molecular characterization of the human COQ5 C-methyltransferase in coenzyme Q10 biosynthesis. Biochimica et biophysica acta, 1841(11), 1628-38. https://doi.org/10.1016/j.bbalip.2014.08.007
Nguyen, Theresa P T, et al. "Molecular characterization of the human COQ5 C-methyltransferase in coenzyme Q10 biosynthesis." Biochimica et biophysica acta vol. 1841,11 (2014): 1628-38. doi: https://doi.org/10.1016/j.bbalip.2014.08.007
Nguyen TP, Casarin A, Desbats MA, Doimo M, Trevisson E, Santos-Ocaña C, Navas P, Clarke CF, Salviati L. Molecular characterization of the human COQ5 C-methyltransferase in coenzyme Q10 biosynthesis. Biochim Biophys Acta. 2014 Nov;1841(11):1628-38. doi: 10.1016/j.bbalip.2014.08.007. Epub 2014 Aug 23. PMID: 25152161; PMCID: PMC4331671.
Copy Download .nbib Format: NLM
Immunomodulatory activity of aged garlic extract against implanted fibrosarcoma tumor in mice.

North American journal of medical sciences

Fallah-Rostami F, Tabari MA, Esfandiari B, Aghajanzadeh H, Behzadi MY.
PMID: 23626957
N Am J Med Sci. 2013 Mar;5(3):207-12. doi: 10.4103/1947-2714.109191.

BACKGROUND: Garlic is known as a medicinal herb with broad therapeutic properties ranging from antibacterial to anticancer and even anticoagulant.AIM: Current study was designed to evaluate antitumor effects of aged garlic extract (AGE) on fibrosarcoma tumor in BALB/c mice.MATERIALS...

Cite
Fallah-Rostami F, Tabari MA, Esfandiari B, et al. Immunomodulatory activity of aged garlic extract against implanted fibrosarcoma tumor in mice. N Am J Med Sci. 2013;5(3):207-12doi: 10.4103/1947-2714.109191.
Fallah-Rostami, F., Tabari, M. A., Esfandiari, B., Aghajanzadeh, H., & Behzadi, M. Y. (2013). Immunomodulatory activity of aged garlic extract against implanted fibrosarcoma tumor in mice. North American journal of medical sciences, 5(3), 207-12. https://doi.org/10.4103/1947-2714.109191
Fallah-Rostami, Fatemeh, et al. "Immunomodulatory activity of aged garlic extract against implanted fibrosarcoma tumor in mice." North American journal of medical sciences vol. 5,3 (2013): 207-12. doi: https://doi.org/10.4103/1947-2714.109191
Fallah-Rostami F, Tabari MA, Esfandiari B, Aghajanzadeh H, Behzadi MY. Immunomodulatory activity of aged garlic extract against implanted fibrosarcoma tumor in mice. N Am J Med Sci. 2013 Mar;5(3):207-12. doi: 10.4103/1947-2714.109191. PMID: 23626957; PMCID: PMC3632025.
Copy Download .nbib Format: NLM
Frequency and time-frequency analysis of intraoperative ECoG during awake brain stimulation.

Frontiers in neuroengineering

Formaggio E, Storti SF, Tramontano V, Casarin A, Bertoldo A, Fiaschi A, Talacchi A, Sala F, Toffolo GM, Manganotti P.
PMID: 23443302
Front Neuroeng. 2013 Feb 25;6:1. doi: 10.3389/fneng.2013.00001. eCollection 2013.

Electrocortical stimulation remains the standard for functional brain mapping of eloquent areas to prevent postoperative functional deficits. The aim of this study was to investigate whether the short-train technique (monopolar stimulation) and Penfield's technique (bipolar stimulation) would induce different...

Cite
Formaggio E, Storti SF, Tramontano V, et al. Frequency and time-frequency analysis of intraoperative ECoG during awake brain stimulation. Front Neuroeng. 2013;6:1doi: 10.3389/fneng.2013.00001.
Formaggio, E., Storti, S. F., Tramontano, V., Casarin, A., Bertoldo, A., Fiaschi, A., Talacchi, A., Sala, F., Toffolo, G. M., & Manganotti, P. (2013). Frequency and time-frequency analysis of intraoperative ECoG during awake brain stimulation. Frontiers in neuroengineering, 61. https://doi.org/10.3389/fneng.2013.00001
Formaggio, Emanuela, et al. "Frequency and time-frequency analysis of intraoperative ECoG during awake brain stimulation." Frontiers in neuroengineering vol. 6 (2013): 1. doi: https://doi.org/10.3389/fneng.2013.00001
Formaggio E, Storti SF, Tramontano V, Casarin A, Bertoldo A, Fiaschi A, Talacchi A, Sala F, Toffolo GM, Manganotti P. Frequency and time-frequency analysis of intraoperative ECoG during awake brain stimulation. Front Neuroeng. 2013 Feb 25;6:1. doi: 10.3389/fneng.2013.00001. eCollection 2013. PMID: 23443302; PMCID: PMC3580919.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 190 entries